Time New York: Sun 19 Nov 11:11 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Ohr Pharmaceutical (OHRP) Jumps: Stock Adds 15% in Session

Zacks

Ohr Pharmaceutical, Inc. OHRP was a big mover last session, as its shares rose 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of 66 cents to 88 cents in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Ohr Pharmaceutical currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Ohr Pharmaceuticals, Inc. Price


Ohr Pharmaceuticals, Inc. Price | Ohr Pharmaceuticals, Inc. Quote

A better-ranked stock in the Medical – Drugs space is Grifols, S.A. GRFS, sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Sell These Stocks. Now.

Just released, today's 220 Zacks Rank #5 Strong Sells demand urgent attention. If any are lurking in your portfolio or Watch List, they should be removed immediately. These sinister are companies because many appear to be sound investments. However, from 1988 through 2016, stocks from our Strong Sell list have actually performed 6X worse than the S&P 500.

See today's Zacks "Strong Sells" absolutely free >>.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.